Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity

Tobramycin-based cationic amphiphiles differing in the chemical bond linking their hydrophobic and hydrophilic parts were synthesized and biologically evaluated. Several compounds demonstrated potent antimicrobial activities compared to the parent drug. One analogue exhibited a significant reduction...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MedChemComm 2013, Vol.4 (1), p.120-124
Hauptverfasser: Herzog, Ido M., Feldman, Mark, Eldar-Boock, Anat, Satchi-Fainaro, Ronit, Fridman, Micha
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 124
container_issue 1
container_start_page 120
container_title MedChemComm
container_volume 4
creator Herzog, Ido M.
Feldman, Mark
Eldar-Boock, Anat
Satchi-Fainaro, Ronit
Fridman, Micha
description Tobramycin-based cationic amphiphiles differing in the chemical bond linking their hydrophobic and hydrophilic parts were synthesized and biologically evaluated. Several compounds demonstrated potent antimicrobial activities compared to the parent drug. One analogue exhibited a significant reduction in red blood cells hemolysis, demonstrating that it is possible to maintain the antimicrobial potency of these molecules while reducing their undesired hemolytic effect through chemical modifications.
doi_str_mv 10.1039/C2MD20162C
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1039_C2MD20162C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1039_C2MD20162C</sourcerecordid><originalsourceid>FETCH-LOGICAL-c231t-5da8d2a944d23f544bedd694bca0f2f2b7f9360070dbd213c30c284bfe50f4623</originalsourceid><addsrcrecordid>eNpFUEtLxDAYDKLgsu7FX5CzUP3yJe22R-n6ghUvei55tpE-liQq_fd2UXQYmGEY5jCEXDK4ZsCrmxqfdwiswPqErBAEZJgzdvrngZ-TTYzvsIBjWVZiRdTORt-OdHJ0sIMKcrQ0ydDa5MeWpmlJhln7MVMyWkO1TH4avaZyOHR-YW8j_fKpo8GaD700OjtM_ZyOFZ38p0_zBTlzso9286tr8nZ_91o_ZvuXh6f6dp9p5CxluZGlQVkJYZC7XAhljSkqobQEhw7V1lW8ANiCUQYZ1xw0lkI5m4MTBfI1ufrZ1WGKMVjXHIIfZJgbBs3xoOb_IP4NF79aIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity</title><source>Royal Society Of Chemistry Journals 2008-</source><source>Alma/SFX Local Collection</source><creator>Herzog, Ido M. ; Feldman, Mark ; Eldar-Boock, Anat ; Satchi-Fainaro, Ronit ; Fridman, Micha</creator><creatorcontrib>Herzog, Ido M. ; Feldman, Mark ; Eldar-Boock, Anat ; Satchi-Fainaro, Ronit ; Fridman, Micha</creatorcontrib><description>Tobramycin-based cationic amphiphiles differing in the chemical bond linking their hydrophobic and hydrophilic parts were synthesized and biologically evaluated. Several compounds demonstrated potent antimicrobial activities compared to the parent drug. One analogue exhibited a significant reduction in red blood cells hemolysis, demonstrating that it is possible to maintain the antimicrobial potency of these molecules while reducing their undesired hemolytic effect through chemical modifications.</description><identifier>ISSN: 2040-2503</identifier><identifier>EISSN: 2040-2511</identifier><identifier>DOI: 10.1039/C2MD20162C</identifier><language>eng</language><ispartof>MedChemComm, 2013, Vol.4 (1), p.120-124</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c231t-5da8d2a944d23f544bedd694bca0f2f2b7f9360070dbd213c30c284bfe50f4623</citedby><cites>FETCH-LOGICAL-c231t-5da8d2a944d23f544bedd694bca0f2f2b7f9360070dbd213c30c284bfe50f4623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022,27922,27923,27924</link.rule.ids></links><search><creatorcontrib>Herzog, Ido M.</creatorcontrib><creatorcontrib>Feldman, Mark</creatorcontrib><creatorcontrib>Eldar-Boock, Anat</creatorcontrib><creatorcontrib>Satchi-Fainaro, Ronit</creatorcontrib><creatorcontrib>Fridman, Micha</creatorcontrib><title>Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity</title><title>MedChemComm</title><description>Tobramycin-based cationic amphiphiles differing in the chemical bond linking their hydrophobic and hydrophilic parts were synthesized and biologically evaluated. Several compounds demonstrated potent antimicrobial activities compared to the parent drug. One analogue exhibited a significant reduction in red blood cells hemolysis, demonstrating that it is possible to maintain the antimicrobial potency of these molecules while reducing their undesired hemolytic effect through chemical modifications.</description><issn>2040-2503</issn><issn>2040-2511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpFUEtLxDAYDKLgsu7FX5CzUP3yJe22R-n6ghUvei55tpE-liQq_fd2UXQYmGEY5jCEXDK4ZsCrmxqfdwiswPqErBAEZJgzdvrngZ-TTYzvsIBjWVZiRdTORt-OdHJ0sIMKcrQ0ydDa5MeWpmlJhln7MVMyWkO1TH4avaZyOHR-YW8j_fKpo8GaD700OjtM_ZyOFZ38p0_zBTlzso9286tr8nZ_91o_ZvuXh6f6dp9p5CxluZGlQVkJYZC7XAhljSkqobQEhw7V1lW8ANiCUQYZ1xw0lkI5m4MTBfI1ufrZ1WGKMVjXHIIfZJgbBs3xoOb_IP4NF79aIw</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Herzog, Ido M.</creator><creator>Feldman, Mark</creator><creator>Eldar-Boock, Anat</creator><creator>Satchi-Fainaro, Ronit</creator><creator>Fridman, Micha</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2013</creationdate><title>Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity</title><author>Herzog, Ido M. ; Feldman, Mark ; Eldar-Boock, Anat ; Satchi-Fainaro, Ronit ; Fridman, Micha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c231t-5da8d2a944d23f544bedd694bca0f2f2b7f9360070dbd213c30c284bfe50f4623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Herzog, Ido M.</creatorcontrib><creatorcontrib>Feldman, Mark</creatorcontrib><creatorcontrib>Eldar-Boock, Anat</creatorcontrib><creatorcontrib>Satchi-Fainaro, Ronit</creatorcontrib><creatorcontrib>Fridman, Micha</creatorcontrib><collection>CrossRef</collection><jtitle>MedChemComm</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herzog, Ido M.</au><au>Feldman, Mark</au><au>Eldar-Boock, Anat</au><au>Satchi-Fainaro, Ronit</au><au>Fridman, Micha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity</atitle><jtitle>MedChemComm</jtitle><date>2013</date><risdate>2013</risdate><volume>4</volume><issue>1</issue><spage>120</spage><epage>124</epage><pages>120-124</pages><issn>2040-2503</issn><eissn>2040-2511</eissn><abstract>Tobramycin-based cationic amphiphiles differing in the chemical bond linking their hydrophobic and hydrophilic parts were synthesized and biologically evaluated. Several compounds demonstrated potent antimicrobial activities compared to the parent drug. One analogue exhibited a significant reduction in red blood cells hemolysis, demonstrating that it is possible to maintain the antimicrobial potency of these molecules while reducing their undesired hemolytic effect through chemical modifications.</abstract><doi>10.1039/C2MD20162C</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2040-2503
ispartof MedChemComm, 2013, Vol.4 (1), p.120-124
issn 2040-2503
2040-2511
language eng
recordid cdi_crossref_primary_10_1039_C2MD20162C
source Royal Society Of Chemistry Journals 2008-; Alma/SFX Local Collection
title Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T05%3A42%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20of%20membrane%20targeting%20tobramycin-based%20cationic%20amphiphiles%20with%20reduced%20hemolytic%20activity&rft.jtitle=MedChemComm&rft.au=Herzog,%20Ido%20M.&rft.date=2013&rft.volume=4&rft.issue=1&rft.spage=120&rft.epage=124&rft.pages=120-124&rft.issn=2040-2503&rft.eissn=2040-2511&rft_id=info:doi/10.1039/C2MD20162C&rft_dat=%3Ccrossref%3E10_1039_C2MD20162C%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true